Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30.2M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
2.98M
-
Shares change
-
-515K
-
Total reported value, excl. options
-
$19M
-
Value change
-
-$5.82M
-
Number of buys
-
10
-
Number of sells
-
-25
-
Price
-
$6.39
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q2 2017
38 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2017.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.98M shares
of 30.2M outstanding shares and own 9.85% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (769K shares), Cormorant Asset Management, LLC (750K shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (640K shares), SCHOLTZ & COMPANY, LLC (251K shares), VANGUARD GROUP INC (234K shares), BAKER BROS. ADVISORS LP (125K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (97.1K shares), BLAIR WILLIAM & CO/IL (26.3K shares), ELEMENT CAPITAL MANAGEMENT LLC (21.1K shares), and BlackRock Inc. (14.8K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.